Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;8(1):e000908.
doi: 10.1136/bmjresp-2021-000908.

Symptomatic, biochemical and radiographic recovery in patients with COVID-19

Affiliations

Symptomatic, biochemical and radiographic recovery in patients with COVID-19

Patrick Mallia et al. BMJ Open Respir Res. 2021 Apr.

Abstract

Background: The symptoms, radiography, biochemistry and healthcare utilisation of patients with COVID-19 following discharge from hospital have not been well described.

Methods: Retrospective analysis of 401 adult patients attending a clinic following an index hospital admission or emergency department attendance with COVID-19. Regression models were used to assess the association between characteristics and persistent abnormal chest radiographs or breathlessness.

Results: 75.1% of patients were symptomatic at a median of 53 days post discharge and 72 days after symptom onset and chest radiographs were abnormal in 47.4%. Symptoms and radiographic abnormalities were similar in PCR-positive and PCR-negative patients. Severity of COVID-19 was significantly associated with persistent radiographic abnormalities and breathlessness. 18.5% of patients had unscheduled healthcare visits in the 30 days post discharge.

Conclusions: Patients with COVID-19 experience persistent symptoms and abnormal blood biomarkers with a gradual resolution of radiological abnormalities over time. These findings can inform patients and clinicians about expected recovery times and plan services for follow-up of patients with COVID-19.

Keywords: COVID-19.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. WHO coronavirus (COVID-19) Dashboard. Available: https://covid19.who.int/ [Accessed 18 Feb 2021].
    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Carfì A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603–5. 10.1001/jama.2020.12603 - DOI - PMC - PubMed
    1. Halpin SJ, McIvor C, Whyatt G, et al. . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021;93:1013–22. 10.1002/jmv.26368 - DOI - PubMed
    1. Wang X, Xu H, Jiang H, et al. . Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM 2020;113:657–65. 10.1093/qjmed/hcaa178 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources